References:
1) Elsevier.com. (2019). ClinicalKey | Elsevier. [online]
Available at: https://www.elsevier.com/solutions/clinicalkey [Accessed
2 Jun. 2019].
2) Osaki et al. Familial dysalbuminemic Hyperthyroxinemia in a Japanese
Man Caused by a point albumin Gene Mutation (R218p). Japanese Clinical
Medicine 2016:7 9–13 doi:10.4137/JCM.s38990
3) Endocrine Press | Endocrine Society. Press.endocrine.org.
2019. [accessed 2 Jun 2019] Available from:
http://press.endocrine.org/doi/full/10.1210/jcem.85.8.6746
4) ClinicalKey. Clinicalkey.com. 2019. [accessed 2 Jun 2019]
Available from:
https://www.clinicalkey.com/#!/content/medline/2-s2.0-6173750
5) 1. OMIM Entry - # 615999 - HYPERTHYROXINEMIA, FAMILIAL
DYSALBUMINEMIC; FDAH [Internet]. Omim.org. 2021 [cited 15 March
2021]. Available from: http://www.omim.org/entry/61599
6) 2. Registration - Thyroid Disease Manager [Internet]. Thyroid
Disease Manager. 2021 [cited 15 March 2021]. Available from:
http://www.thyroidmanager.org/chapter/assay-of-thyroid-hormones-and-related-substances/
7) 3. Euthyroid Hyperthyroxinemia Clinical Presentation: History,
Physical, Causes [Internet]. Emedicine.medscape.com. 2021 [cited
15 March 2021]. Available from:
http://emedicine.medscape.com/article/118562-clinical#b5